The Interleukin-17/Interleukin-22 Innate Axis in the Gut as a New Drug Target in Allergic-Inflammatory and Autoimmune Diseases. A Working Hypothesis

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|14|2|145-151

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.14, Iss.2, 2014-06, pp. : 145-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases

By Yan Jun-Wei   Wang Yu-Jie   Peng Wen-Jia   Tao Jin-Hui   Wan Ya-Nan   Li Bao-Zhu   Mei Bin   Chen Bing   Yao Hua   Yang Guo-Jun   Li Xiang-Pei   Ye Dong-Qing   Wang Jing  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 1, 2014-01 ,pp. : 29-41

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-25: Key Regulator of Inflammatory and Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 34, 2011-11 ,pp. : 3781-3785

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-21 in Immune and Allergic Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 313-319

Bentham Science Publishers

Access to resources Recommend Favorite

The inhibition of interleukin 5 in allergic diseases

By Minnicozzi M.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 147-156

Informa Healthcare

Access to resources Recommend Favorite

Targeting interleukin-21 in inflammatory diseases

By Sarra Massimiliano   Franzèè Eleonora   Pallone Francesco   Monteleone Giovanni  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 6, 2011-06 ,pp. : 695-702

Informa Healthcare

Access to resources Recommend Favorite